Mavingire, N.; Moore, J.C.; Johnson, J.R.; Dwead, A.M.; Cropp, C.D.; Mechref, Y.; Kobeissy, F.; Rais-Bahrami, S.; Woods-Burnham, L.
Revisiting HER2 in Prostate Cancer from an Inclusive Perspective: From Biomarkers to Omics. Cancers 2024, 16, 3262.
https://doi.org/10.3390/cancers16193262
AMA Style
Mavingire N, Moore JC, Johnson JR, Dwead AM, Cropp CD, Mechref Y, Kobeissy F, Rais-Bahrami S, Woods-Burnham L.
Revisiting HER2 in Prostate Cancer from an Inclusive Perspective: From Biomarkers to Omics. Cancers. 2024; 16(19):3262.
https://doi.org/10.3390/cancers16193262
Chicago/Turabian Style
Mavingire, Nicole, Janelle C. Moore, Jabril R. Johnson, Abdulrahman M. Dwead, Cheryl D. Cropp, Yehia Mechref, Firas Kobeissy, Soroush Rais-Bahrami, and Leanne Woods-Burnham.
2024. "Revisiting HER2 in Prostate Cancer from an Inclusive Perspective: From Biomarkers to Omics" Cancers 16, no. 19: 3262.
https://doi.org/10.3390/cancers16193262
APA Style
Mavingire, N., Moore, J. C., Johnson, J. R., Dwead, A. M., Cropp, C. D., Mechref, Y., Kobeissy, F., Rais-Bahrami, S., & Woods-Burnham, L.
(2024). Revisiting HER2 in Prostate Cancer from an Inclusive Perspective: From Biomarkers to Omics. Cancers, 16(19), 3262.
https://doi.org/10.3390/cancers16193262